• InstaBlue Protein Stain Solution Protocol

  2026-08-17

  InstaBlue Protein Stain Solution provides rapid Coomassie Brilliant Blue visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and mass spectrometry workflows, but should be validated separately when legacy methanol/acetic acid chemistry or fully quantitative densitometry is required.

• Z-WEHD-FMK for Caspase-1 Pathway Studies

  2026-08-17

  Z-WEHD-FMK enables cell-permeable, irreversible inhibition of inflammatory caspases in pyroptosis, infection, and Golgi-fragmentation workflows. This guide shows how to use it as a mechanistic tool while avoiding the common mistake of interpreting broad caspase blockade as caspase-1-specific proof.

• Oseltamivir acid: Assay Design for Influenza Research

  2026-08-16

  Oseltamivir acid is an influenza neuraminidase inhibitor with value across mechanistic virology, resistance studies, and exploratory oncology research. This article presents an assay-centered framework that separates direct target inhibition, viral spread, compound handling, and species-dependent prodrug interpretation.

• From MAPK10 Mechanism to Protein Assay Strategy

  2026-08-15

  Mechanistic oncology is only as reliable as the protein workflow behind it. This thought-leadership article connects the MAPK10/KRT16/RNF213 axis in NSCLC with practical guidance for preserving phosphorylation, ubiquitination, and native protein interactions during translational sample preparation.

• Making Bone-Repair Signals Translationally Measurable

  2026-08-14

  Bone transport offers a compelling model of angiogenic and osteo-immune coupling, but its translational value depends on molecular measurements that are specific, reproducible, and linked to tissue outcomes. This article examines how RT-qPCR can validate TGF-β1/TGFBR1-associated repair biology and how HotStart™ Universal 2X Green qPCR Master Mix supports rigorous dye-based workflows.

• Ibuprofen Workflows for Cancer Research

  2026-08-13

  Build reproducible Ibuprofen experiments around COX inhibition, concentration–response design, apoptosis induction, and cell-cycle profiling. The workflow also adapts a protein–drug interaction strategy from a mubritinib–albumin study, helping researchers separate cellular activity from solubility, vehicle, and distribution artifacts.

• Diphenyleneiodonium Chloride: Redox Assay Guide

  2026-08-13

  Diphenyleneiodonium chloride, or DPI, is a versatile perturbation tool for separating NADH oxidase, nitric oxide synthase, cytochrome P450 reductase, and GPR3-linked cAMP effects. This workflow connects DPI-based redox experiments with the iron, ROS, and ferroptosis framework reported in citrus canker research while emphasizing controls that prevent overinterpretation.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome

  2026-08-12

  This case report documents neuroleptic malignant syndrome after standard-dose prochlorperazine in a 76-year-old man, emphasizing that diagnosis can remain clinically compelling despite limited or delayed laboratory abnormalities. The report also illustrates how medication history, neurological examination, exclusion of mimics, and prompt benzodiazepine- and amantadine-based treatment can guide recovery.

• Low-Molecular Weight Inhibitors of Complement

  2026-08-12

  The reference review explains why complement factor B and factor D are attractive targets for selectively suppressing alternative-pathway amplification. It connects pathway biochemistry, medicinal chemistry, pharmacology, and early clinical translation while highlighting how orally available inhibitors can support research and treatment development across complement-mediated diseases.

• Sulfo-Cy5 Carboxylic Acid in Nano-Adjuvant Imaging

  2026-08-11

  Sulfo-Cy5 carboxylic acid brings aqueous compatibility and near-infrared signal to workflows that track proteins, peptides, and nanoparticle-associated cargo. Its sulfonated structure can reduce dye aggregation, while the reference nano-adjuvant study provides a practical framework for studying sustained release and intestinal targeting.

• NF449 and Selective Platelet P2X1 Blockade

  2026-08-11

  The reference study established NF449 as a comparatively selective antagonist of the platelet P2X1 receptor and used complementary human platelet and mouse thrombosis models to connect receptor blockade with reduced platelet activation. Its findings show that P2X1 contributes to collagen-driven aggregation and thrombus formation, while also demonstrating that dose escalation reduces receptor selectivity and may increase translational risk.

• Benzyl Quinolone Carboxylic Acid and M1 Bias

  2026-08-10

  Benzyl Quinolone Carboxylic Acid (BQCA) is more than a selective M1 probe: it can reveal how receptor state, GRK recruitment, and assay timing shape acetylcholine receptor signaling. This guide translates recent BRET findings into practical experimental decisions for cognitive and Alzheimer’s disease research.

• Applied mCherry mRNA Workflows for Cell Assays

  2026-08-09

  EZ Cap™ mCherry mRNA provides a Cap 1, modified-nucleotide reporter for tracking delivery, localization, and fluorescent protein expression in living cells. This guide connects practical cell-assay setup with nanoparticle loading lessons from a kidney-targeted mRNA study, while separating validated product attributes from workflow starting points.

• Iptacopan: Designing Better Complement Assays

  2026-08-08

  Iptacopan (LNP023) offers a precise way to interrogate alternative-pathway amplification. This guide connects factor B pharmacology with assay design, endpoint selection, and translational interpretation across complement activation research.

• Praeruptorin A Suppresses NF-κB in RAW264.7 Cells

  2026-08-07

  This study examines how Praeruptorin A modulates poly(I:C)-induced inflammation in RAW264.7 macrophages, combining transcriptomic screening with molecular validation. Its findings connect Praeruptorin A with reduced inflammatory gene expression and NF-κB pathway activation, while also defining a practical concentration window for in vitro inflammation assays.

8602 records 4/574 page Previous Next 12345 下5页 Last page